A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
- PMID: 11586362
- DOI: 10.1038/35097097
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a prototype autoimmune disease mediated by type 1 helper T (TH1) cells and under the control of regulatory cells. Here we report that a synthetic glycolipid ligand for CD1d-restricted natural killer T (NKT) cells expressing the semi-invariant T-cell receptor (Valpha14+) is preventive against EAE. The ligand is an analogue of alpha-galactosylceramide (alpha-GC), a prototype NKT cell ligand, with a truncated sphingosine chain. alpha-GC causes NKT cells to produce both interferon (IFN)-gamma and interleukin (IL)-4 (refs 4, 5). However, this new ligand can induce a predominant production of IL-4 by the NKT cells. A single injection of this glycolipid, but not of alpha-GC, consistently induced TH2 bias of autoimmune T cells by causing NKT cells to produce IL-4, leading to suppression of EAE. The lack of polymorphism of CD1d and cross-reactive response of mouse and human NKT cells to the same ligand indicates that targeting NKT cells with this ligand may be an attractive means for intervening in human autoimmune diseases such as multiple sclerosis.
Similar articles
-
Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.Shock. 2008 Feb;29(2):269-77. doi: 10.1097/shk.0b013e31811ff60c. Shock. 2008. PMID: 17693934
-
[Synthetic glycolipid ligands as novel therapeutics for multiple sclerosis].Rinsho Shinkeigaku. 2005 Nov;45(11):909-11. Rinsho Shinkeigaku. 2005. PMID: 16447760 Review. Japanese.
-
[Treatment for multiple sclerosis with a synthetic glycolipid].Nihon Rinsho. 2003 Aug;61(8):1442-8. Nihon Rinsho. 2003. PMID: 12962036 Review. Japanese.
-
Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.Nat Med. 2001 Sep;7(9):1057-62. doi: 10.1038/nm0901-1057. Nat Med. 2001. PMID: 11533711
-
The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice.Nat Med. 2001 Sep;7(9):1052-6. doi: 10.1038/nm0901-1052. Nat Med. 2001. PMID: 11533710
Cited by
-
Berberine: A natural modulator of immune cells in multiple sclerosis.Immun Inflamm Dis. 2024 Mar;12(3):e1213. doi: 10.1002/iid3.1213. Immun Inflamm Dis. 2024. PMID: 38477663 Free PMC article. Review.
-
Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers.Mol Neurobiol. 2024 Mar 4. doi: 10.1007/s12035-024-03999-8. Online ahead of print. Mol Neurobiol. 2024. PMID: 38436833 Review.
-
The immune system in neurological diseases: What innate-like T cells have to say.J Allergy Clin Immunol. 2024 Apr;153(4):913-923. doi: 10.1016/j.jaci.2024.02.003. Epub 2024 Feb 15. J Allergy Clin Immunol. 2024. PMID: 38365015 Review.
-
Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial.JMIR Res Protoc. 2024 Jan 15;13:e46709. doi: 10.2196/46709. JMIR Res Protoc. 2024. PMID: 38224478 Free PMC article.
-
Natural Killer T (NKT) Cells in Autoimmune Hepatitis: Current Evidence from Basic and Clinical Research.Cells. 2023 Dec 18;12(24):2854. doi: 10.3390/cells12242854. Cells. 2023. PMID: 38132174 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous